
Elevance Health Raises 2026 Adjusted EPS Guidance to $27.00 Amid Rising Medical Costs
Elevance Health, Inc.Description
What this story covers
Elevance Health reported $49.8 billion in revenue but faced profit declines due to rising medical costs and membership attrition. Despite these headwinds, the company raised its 2026 adjusted EPS guidance to at least $27.00, pivoting toward its Carelon services.
Story snapshot
CompanyElevance Health, Inc.
TickerELV
VariantStandard detailed
Duration4:03
Filing type8-K
PeriodQ3 2026
IndustryHealthcare & Pharmaceuticals
Accession0001156039-26-000058
Sources1
Full Story Script
Content not available for this story.